Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Pesticide acute toxicity testing determines the adverse health effects of a pesticide following single or short-term exposure via the oral, dermal, or inhalation routes, with results typically expressed as LD50 or LC50 values. As a core data requirement for pesticide registration, GHS hazard classification, and safety labeling worldwide, acute toxicity studies must be performed in GLP-compliant facilities following internationally recognized protocols such as OECD Test Guidelines and national standards. This article explains the sample types, test items, methods, and applications involved in pesticide acute toxicity determination.

Technical Overview

Pesticide acute toxicity refers to the adverse effects that occur in test animals following a single exposure to a pesticide, or multiple exposures within a 24-hour period, through the oral, dermal, or inhalation route. The central quantitative endpoints of these studies are the median lethal dose (LD50), expressed in mg/kg body weight for oral and dermal exposure, and the median lethal concentration (LC50), expressed in mg/L of air for inhalation exposure.

Acute toxicity data serve as the scientific basis for hazard classification and labeling under the Globally Harmonized System (GHS), the WHO Recommended Classification of Pesticides by Hazard (Classes Ia, Ib, II, III, and U), and national regulatory schemes. These data directly determine signal words, hazard pictograms, precautionary statements, first-aid instructions, and personal protective equipment (PPE) requirements on product labels. Acute toxicity studies are mandatory components of pesticide registration dossiers in virtually all major jurisdictions, and the tests must be conducted in accordance with Good Laboratory Practice (GLP) principles in accredited third-party laboratories or government-recognized testing institutions.

Testing Samples

Technical Grade Active Ingredients

The technical material (TC), representing the purified active substance with a declared minimum purity, is the primary test subject for pesticide registration. Acute toxicity characterization of the active ingredient establishes the intrinsic hazard profile of the compound and typically forms the reference dataset for subsequent formulation studies.

Formulated Products

Commercial formulations, including emulsifiable concentrates (EC), wettable powders (WP), suspension concentrates (SC), soluble liquids (SL), water-dispersible granules (WG), and granules (GR), must also be evaluated. Because solvents, surfactants, and carriers can significantly alter the toxicity profile of the active ingredient, the finished product may exhibit a higher or lower hazard class than the technical material itself.

Sample Submission Requirements

Submitted samples should be accompanied by a certificate of analysis specifying purity, batch number, physical-chemical properties, stability data, and recommended storage conditions. Adequate quantity must be provided to cover dose range-finding and main studies, and samples must remain within their validated shelf life throughout the testing period.

Testing Items

A complete acute toxicity evaluation package for pesticide registration generally includes the following endpoints:

  • Acute oral toxicity (LD50) in rodents
  • Acute dermal toxicity (LD50) in rats or rabbits
  • Acute inhalation toxicity (4-hour LC50) in rats
  • Acute eye irritation and corrosion potential
  • Acute dermal irritation and corrosion potential
  • Skin sensitization potential

In addition to the lethal endpoints, studies document clinical signs of toxicity (such as tremors, salivation, lethargy, or convulsions), time of onset and recovery, body weight changes, gross necropsy findings, and any target-organ effects observed. These supplementary observations are critical for hazard labeling and risk mitigation decisions.

Testing Methods

Governing Standards and Guidelines

Acute toxicity studies are conducted according to internationally harmonized test guidelines, including:

  • OECD Test Guideline 420: Acute Oral Toxicity – Fixed Dose Procedure
  • OECD Test Guideline 423: Acute Oral Toxicity – Acute Toxic Class Method
  • OECD Test Guideline 425: Acute Oral Toxicity – Up-and-Down Procedure
  • OECD Test Guideline 402: Acute Dermal Toxicity
  • OECD Test Guideline 403: Acute Inhalation Toxicity (and TG 436, Acute Toxic Class Method)
  • GB 15670: Toxicological Testing Methods for Pesticide Registration (Chinese national standard series)
  • US EPA OCSPP 870.1100 (oral), 870.1200 (dermal), and 870.1300 (inhalation) harmonized guidelines

Test Systems and Procedures

Commonly used test species include Sprague-Dawley or Wistar rats, mice for certain oral studies, New Zealand White rabbits for dermal and eye irritation testing, and guinea pigs or mice for skin sensitization assessment. After an acclimatization period, the test substance is administered at predetermined dose levels via gavage, dermal application, or whole-body or nose-only inhalation exposure. Animals are observed for clinical signs and mortality for at least 14 days post-dosing, followed by gross necropsy. The LD50 or LC50, along with confidence intervals and observed toxicity thresholds, is calculated using the statistical approach prescribed by the selected guideline.

Quality and Ethical Compliance

All studies intended for regulatory submission must comply with GLP regulations, and testing facilities operate under animal ethics committee oversight consistent with the 3Rs principles (replacement, reduction, and refinement) to minimize animal use while maintaining scientific validity. Validated in vitro methods, such as reconstructed human epidermis models for skin corrosion (OECD TG 431) and bovine cornea or isolated eye methods for eye irritation, are increasingly accepted as adjuncts or replacements for specific endpoints where regulatory frameworks permit.

Applications

Acute toxicity data generated through these studies support a wide range of regulatory and commercial purposes:

  • Pesticide registration dossiers submitted to national authorities, such as China's pesticide registration system, the EU under Regulation (EC) No 1107/2009, and the US EPA under FIFRA
  • GHS-based hazard classification and labeling, including signal word assignment and pictogram selection
  • Preparation of Safety Data Sheets (SDS) in compliance with GHS, CLP, and national provisions
  • Dangerous goods classification for transport under the UN Model Regulations, ADR, IATA, and IMDG codes
  • Occupational risk assessment, including handler PPE requirements, restricted-entry intervals, and first-aid guidance
  • Comparative formulation development and product stewardship programs

FAQ

What does LD50 mean? The LD50 (median lethal dose) is the statistically derived single dose of a substance that is expected to cause death in 50 percent of test animals under defined conditions. Lower LD50 values indicate higher acute toxicity.

Which test animals are used? Acute oral and inhalation studies typically use rats (or mice for oral studies), dermal toxicity studies use rats or rabbits, eye and skin irritation studies use rabbits, and sensitization studies use guinea pigs or mice.

How long does an acute toxicity study take? Including acclimatization, dose administration, the mandatory 14-day observation period, necropsy, and report finalization, a standard study is usually completed within three to six weeks.

Is GLP compliance mandatory? Yes. Regulatory authorities worldwide only accept acute toxicity data for pesticide registration when the studies have been conducted in GLP-compliant laboratories with full documentation of study conduct and quality assurance audit.

Can in vitro methods replace animal testing? For certain local endpoints such as skin corrosion and serious eye damage, validated in vitro methods are accepted in several jurisdictions. However, systemic endpoints such as oral, dermal, and inhalation LD50/LC50 currently still require in vivo testing under most pesticide regulatory frameworks.